{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:55:18Z","timestamp":1793141718776,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR - PJT-159505"],"award-info":[{"award-number":["CIHR - PJT-159505"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["HSFC - G 23 0035438"],"award-info":[{"award-number":["HSFC - G 23 0035438"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48711-z","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:49:20Z","timestamp":1776426560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intestinal epithelial cell-specific deletion of Jak2 disrupts gut homeostasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Brooke","family":"D\u2019Mello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Pollock-Tahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Uwe","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Streutker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"48711_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390, 2769\u20132778 (2017).","journal-title":"Lancet"},{"key":"48711_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298\u2013306 (2011).","journal-title":"Nature"},{"key":"48711_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799\u2013809 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"48711_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson, L. W. & Artis, D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141\u2013153 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"48711_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.physiol.010908.163145","volume":"71","author":"LG van der Flier","year":"2009","unstructured":"van der Flier, L. G. & Clevers, H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71, 241\u2013260 (2009).","journal-title":"Annu. Rev. Physiol."},{"key":"48711_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-023-00174-7","volume":"12","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. The cyclooxygenase-expressing mesenchyme resists intestinal epithelial injury by paracrine signaling. Cell Regen. 12, 30 (2023).","journal-title":"Cell Regen."},{"key":"48711_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","volume":"13","author":"SH Lee","year":"2015","unstructured":"Lee, S. H. Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases. Intest. Res. 13, 11\u201318 (2015).","journal-title":"Intest. Res."},{"key":"48711_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","volume":"124","author":"KR Groschwitz","year":"2009","unstructured":"Groschwitz, K. R. & Hogan, S. P. Intestinal barrier function: Molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124, 3\u201320 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"48711_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson, D. S. & Horvath, C. M. A road map for those who don\u2019t know Jak-STAT. Science 296, 1653\u20131655 (2002).","journal-title":"Science"},{"key":"48711_CR10","volume":"2","author":"AF Heneghan","year":"2013","unstructured":"Heneghan, A. F., Pierre, J. F. & Kudsk, K. A. Jak-STAT and intestinal mucosal immunology. JAKSTAT 2, e25530 (2013).","journal-title":"JAKSTAT"},{"key":"48711_CR11","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.3748\/wjg.v12.i23.3668","volume":"12","author":"L Halme","year":"2006","unstructured":"Halme, L. et al. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12, 3668\u20133672 (2006).","journal-title":"World J. Gastroenterol."},{"key":"48711_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ecco-jcc\/jjab131","volume":"16","author":"V D\u00edez-Obrero","year":"2022","unstructured":"D\u00edez-Obrero, V. et al. Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories. J. Crohn\u2019s Colitis 16, 275\u2013285 (2022).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"48711_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1001","volume":"7","author":"B Verstockt","year":"2018","unstructured":"Verstockt, B., Smith, K. G. & Lee, J. C. Genome-wide association studies in Crohn\u2019s disease: Past, present and future. Clin. Transl. Immunol. 7, e1001 (2018).","journal-title":"Clin. Transl. Immunol."},{"key":"48711_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00384-011-1345-y","volume":"27","author":"M Prager","year":"2012","unstructured":"Prager, M. et al. The JAK2 variant rs10758669 in Crohn\u2019s disease: Altering the intestinal barrier as one mechanism of action. Int. J. Colorectal Dis. 27, 565\u2013573 (2012).","journal-title":"Int. J. Colorectal Dis."},{"key":"48711_CR15","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.1600845","volume":"197","author":"M Hedl","year":"2016","unstructured":"Hedl, M., Proctor, D. D. & Abraham, C. JAK2 disease-risk variants are gain of function and JAK signaling threshold determines innate receptor-induced proinflammatory cytokine secretion in macrophages. J. Immunol. 197, 3695\u20133704 (2016).","journal-title":"J. Immunol."},{"key":"48711_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","volume":"36","author":"JJ O\u2019Shea","year":"2012","unstructured":"O\u2019Shea, J. J. & Plenge, R. Jak and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542\u2013550 (2012).","journal-title":"Immunity"},{"key":"48711_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2016-312735","volume":"66","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s, J. et al. Tofacitinib for induction and maintenance therapy of Crohn\u2019s disease: Results of two phase IIb randomised placebo-controlled trials. Gut 66, 1049\u20131059 (2017).","journal-title":"Gut"},{"key":"48711_CR18","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","volume":"399","author":"S Danese","year":"2022","unstructured":"Danese, S. et al. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from three phase 3, multicentre, double-blind, randomised trials. Lancet 399, 2113\u20132128 (2022).","journal-title":"Lancet"},{"key":"48711_CR19","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.cgh.2021.12.030","volume":"20","author":"G D\u2019Haens","year":"2022","unstructured":"D\u2019Haens, G. et al. Upadacitinib was efficacious and well-tolerated over 30 months in patients with Crohn\u2019s disease in the CELEST extension study. Clin. Gastroenterol. Hepatol. 20, 2337-2346e.e3 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"48711_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0140-6736(16)32537-5","volume":"389","author":"S Vermeire","year":"2017","unstructured":"Vermeire, S. et al. Clinical remission in patients with moderate-to-severe Crohn\u2019s disease treated with filgotinib (the FITZROY study): Results from a phase 2, double-blind, randomised, placebo-controlled trial. Lancet 389, 266\u2013275 (2017).","journal-title":"Lancet"},{"key":"48711_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03108","author":"A Witalisz-Siepracka","year":"2019","unstructured":"Witalisz-Siepracka, A. et al. Loss of JAK1 drives innate immune deficiency. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.03108 (2019).","journal-title":"Front. Immunol."},{"key":"48711_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4049\/jimmunol.1203084","volume":"191","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells. J. Immunol. 191, 1164\u20131174 (2013).","journal-title":"J. Immunol."},{"key":"48711_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stemcr.2017.11.015","volume":"10","author":"CA Richmond","year":"2018","unstructured":"Richmond, C. A. et al. JAK\/STAT-1 signaling is required for reserve intestinal stem cell activation during intestinal regeneration following acute inflammation. Stem Cell Rep. 10, 17\u201326 (2018).","journal-title":"Stem Cell Rep."},{"key":"48711_CR24","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1053\/j.gastro.2020.07.004","volume":"159","author":"MR Spalinger","year":"2020","unstructured":"Spalinger, M. R. et al. PTPN2 regulates interactions between macrophages and intestinal epithelial cells to promote intestinal barrier function. Gastroenterology 159, 1763-1777e14 (2020).","journal-title":"Gastroenterology"},{"key":"48711_CR25","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.4049\/jimmunol.1700152","volume":"199","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Mumm, J. B., Herbst, R., Kolbeck, R. & Wang, Y. IL-22 increases permeability of intestinal epithelial tight junctions by enhancing claudin-2 expression. J. Immunol. 199, 3316\u20133325 (2017).","journal-title":"J. Immunol."},{"key":"48711_CR26","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1097\/MIB.0000000000000954","volume":"22","author":"M Krishnan","year":"2016","unstructured":"Krishnan, M., Penrose, H. M., Shah, N. N., Marchelletta, R. R. & McCole, D. F. VSL#3 probiotic stimulates T-cell protein tyrosine phosphatase\u2013mediated recovery of IFN-\u03b3\u2013induced intestinal epithelial barrier defects. Inflamm. Bowel Dis. 22, 2811\u20132823 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"48711_CR27","doi-asserted-by":"publisher","first-page":"31263","DOI":"10.1074\/jbc.M111.238147","volume":"286","author":"T Suzuki","year":"2011","unstructured":"Suzuki, T., Yoshinaga, N. & Tanabe, S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J. Biol. Chem. 286, 31263\u201331271 (2011).","journal-title":"J. Biol. Chem."},{"key":"48711_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/nyas.13439","volume":"1405","author":"M Krishnan","year":"2017","unstructured":"Krishnan, M. & McCole, D. F. T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells. Ann. N. Y. Acad. Sci. 1405, 116\u2013130 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"48711_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/gut.2006.094375","volume":"56","author":"S Zeissig","year":"2007","unstructured":"Zeissig, S. et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\u2019s disease. Gut 56, 61\u201372 (2007).","journal-title":"Gut"},{"key":"48711_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217877121","volume":"121","author":"T Oami","year":"2024","unstructured":"Oami, T. et al. Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis. Proc. Natl. Acad. Sci. 121, e2217877121 (2024).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"48711_CR31","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/mi.2014.21","volume":"7","author":"R Ahmad","year":"2014","unstructured":"Ahmad, R. et al. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression and protects from colitis. Mucosal Immunol. 7, 1340\u20131353 (2014).","journal-title":"Mucosal Immunol."},{"key":"48711_CR32","doi-asserted-by":"publisher","DOI":"10.4161\/tisb.28320","volume":"2","author":"H Yang","year":"2014","unstructured":"Yang, H., Rao, J. N. & Wang, J.-Y. Posttranscriptional regulation of intestinal epithelial tight junction barrier by RNA-binding proteins and microRNAs. Tissue Barriers 2, e28320 (2014).","journal-title":"Tissue Barriers"},{"key":"48711_CR33","doi-asserted-by":"publisher","first-page":"32430","DOI":"10.1074\/jbc.271.50.32430","volume":"271","author":"ST Sawyer","year":"1996","unstructured":"Sawyer, S. T. & Penta, K. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction. J. Biol. Chem. 271, 32430\u201332437 (1996).","journal-title":"J. Biol. Chem."},{"key":"48711_CR34","first-page":"1473","volume":"78","author":"MC Delehaye-Zervas","year":"1994","unstructured":"Delehaye-Zervas, M. C. et al. Expression of the growth hormone receptor gene in human digestive tissue. J. Clin. Endocrinol. Metab. 78, 1473\u20131480 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48711_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Sig. Transduct. Target. Ther. 6, 402 (2021).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"48711_CR36","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/mi.2008.46","volume":"1","author":"F Heller","year":"2008","unstructured":"Heller, F., Fromm, A., Gitter, A. H., Mankertz, J. & Schulzke, J. D. Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunol. 1, S58\u2013S61 (2008).","journal-title":"Mucosal Immunol."},{"key":"48711_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller, F. et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550\u2013564 (2005).","journal-title":"Gastroenterology"},{"key":"48711_CR38","doi-asserted-by":"publisher","first-page":"G282","DOI":"10.1152\/ajpgi.00290.2021","volume":"322","author":"NM Walker","year":"2022","unstructured":"Walker, N. M., Liu, J., Young, S. M., Woode, R. A. & Clarke, L. L. Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 322, G282\u2013G293 (2022).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"48711_CR39","doi-asserted-by":"publisher","first-page":"13357","DOI":"10.1074\/jbc.M110.214965","volume":"286","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Interleukin-13 (IL-13)\/IL-13 receptor \u03b11 (IL-13R\u03b11) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl\u2212 secretion *. J. Biol. Chem. 286, 13357\u201313369 (2011).","journal-title":"J. Biol. Chem."},{"key":"48711_CR40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/ibd.21628","volume":"17","author":"MJ Rosen","year":"2011","unstructured":"Rosen, M. J. et al. STAT6 activation in ulcerative colitis: A new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm. Bowel Dis. 17, 2224\u20132234 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"48711_CR41","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1113\/JP271156","volume":"593","author":"P Dames","year":"2015","unstructured":"Dames, P. et al. Interleukin-13 affects the epithelial sodium channel in the intestine by coordinated modulation of STAT6 and p38 MAPK activity. J. Physiol. 593, 5269\u20135282 (2015).","journal-title":"J. Physiol."},{"key":"48711_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03602-3","volume":"31","author":"X Wu","year":"2025","unstructured":"Wu, X. et al. Targeting CXCL8 alleviates intestinal epithelial inflammation by suppressing the JAK-STAT pathway. Eur. J. Med. Res. 31, 30 (2025).","journal-title":"Eur. J. Med. Res."},{"key":"48711_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","volume":"14","author":"UM M\u00f6rbe","year":"2021","unstructured":"M\u00f6rbe, U. M. et al. Human gut-associated lymphoid tissues (GALT); Diversity, structure, and function. Mucosal Immunol. 14, 793\u2013802 (2021).","journal-title":"Mucosal Immunol."},{"key":"48711_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","volume":"52","author":"TM Fenton","year":"2020","unstructured":"Fenton, T. M. et al. Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in the priming of region-specific immunity. Immunity 52, 557\u2013570e6 (2020).","journal-title":"Immunity"},{"key":"48711_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/0471142735.im1525s104","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc. Immunol 104, 15\u201325 (2014).","journal-title":"Curr Protoc. Immunol"},{"key":"48711_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Primers. 6, 1\u201320 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"48711_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee, S., Biehl, A., Gadina, M., Hasni, S. & Schwartz, D. M. JAK\u2013STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects. Drugs 77, 521\u2013546 (2017).","journal-title":"Drugs"},{"key":"48711_CR48","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s10753-015-0180-7","volume":"38","author":"J B\u00e1b\u00ed\u010dkov\u00e1","year":"2015","unstructured":"B\u00e1b\u00ed\u010dkov\u00e1, J. et al. Sex differences in experimentally induced colitis in mice: A role for estrogens. Inflammation 38, 1996\u20132006 (2015).","journal-title":"Inflammation"},{"key":"48711_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.apsb.2024.11.014","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo, Y. et al. Facilitation of mucosal healing by estrogen receptor \u03b2 in ulcerative colitis through suppression of branched-chain amino acid transport and subsequent triggering of autophagy in colonic epithelial cells. Acta Pharm. Sin. B 15, 168\u2013187 (2025).","journal-title":"Acta Pharm. Sin. B"},{"key":"48711_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01974","author":"C Weidinger","year":"2018","unstructured":"Weidinger, C., Ziegler, J. F., Letizia, M., Schmidt, F. & Siegmund, B. Adipokines and their role in intestinal inflammation. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01974 (2018).","journal-title":"Front. Immunol."},{"key":"48711_CR51","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/gut.2004.046516","volume":"54","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto, K. et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn\u2019s disease. Gut 54, 789\u2013796 (2005).","journal-title":"Gut"},{"key":"48711_CR52","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.3748\/wjg.v24.i38.4341","volume":"24","author":"NS Nunes","year":"2018","unstructured":"Nunes, N. S. et al. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J. Gastroenterol. 24, 4341\u20134355 (2018).","journal-title":"World J. Gastroenterol."},{"key":"48711_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451394","volume":"55","author":"S Westermann","year":"2025","unstructured":"Westermann, S., Radtke, D., Kramer, L., Wirtz, S. & Voehringer, D. Activation of STAT6 in intestinal epithelial cells predisposes to gut inflammation. Eur. J. Immunol. 55, e202451394 (2025).","journal-title":"Eur. J. Immunol."},{"key":"48711_CR54","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2119\/molmed.2012.00277","volume":"18","author":"Y Li","year":"2012","unstructured":"Li, Y. et al. STATI, STAT6 and adenosine 3\u2032,5\u2032-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis. Mol. Med. 18, 1412\u20131419 (2012).","journal-title":"Mol. Med."},{"key":"48711_CR55","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41385-019-0204-y","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin, Y. et al. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis. Mucosal Immunol. 12, 1304\u20131315 (2019).","journal-title":"Mucosal Immunol."},{"key":"48711_CR56","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/ecco-jcc\/jjae031","volume":"18","author":"S van Gennep","year":"2024","unstructured":"van Gennep, S. et al. Histological outcomes and JAK-STAT signalling in ulcerative colitis patients treated with tofacitinib. J. Crohns Colitis 18, 1283\u20131291 (2024).","journal-title":"J. Crohns Colitis"},{"key":"48711_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tem.2017.11.001","volume":"29","author":"DW Dodington","year":"2018","unstructured":"Dodington, D. W., Desai, H. R. & Woo, M. JAK\/STAT \u2013 Emerging players in metabolism. Trends Endocrinol. Metab. 29, 55\u201365 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"48711_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07923-0","volume":"7","author":"HR Desai","year":"2017","unstructured":"Desai, H. R. et al. Macrophage JAK2 deficiency protects against high-fat diet-induced inflammation. Sci. Rep. 7, 7653 (2017).","journal-title":"Sci. Rep."},{"key":"48711_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03078-5","volume":"5","author":"I Dotan","year":"2022","unstructured":"Dotan, I. et al. Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux. Commun. Biol. 5, 132 (2022).","journal-title":"Commun. Biol."},{"key":"48711_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/gene.20042","volume":"39","author":"F El Marjou","year":"2004","unstructured":"El Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186\u2013193 (2004).","journal-title":"Genesis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48711-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:03:40Z","timestamp":1781089420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48711-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All studies involving mice were performed according to the guidelines and regulations of the Canadian Council on Animal Care and all animal studies were pre-approved by Toronto General Hospital Research Institute Animal Care Committee (AUP: 852.3).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Institutional review board statement"}}],"article-number":"17886"}}